| Signaling events for metallothionein induction F Haq, M Mahoney, J Koropatnick Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 533 (1 …, 2003 | 509 | 2003 |
| Use of the humanized anti-epidermal growth factor receptor monoclonal antibody h-R3 in combination with radiotherapy in the treatment of locally advanced head and neck cancer … T Crombet, M Osorio, T Cruz, C Roca, R del Castillo, R Mon, ... Journal of Clinical Oncology 22 (9), 1646-1654, 2004 | 402 | 2004 |
| The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1, 2 that sustain high basal motility in breast cancer cells SR Hamilton, SF Fard, FF Paiwand, C Tolg, M Veiseh, C Wang, ... Journal of Biological Chemistry 282 (22), 16667-16680, 2007 | 318 | 2007 |
| Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells KL Morley, PJ Ferguson, J Koropatnick Cancer letters 251 (1), 168-178, 2007 | 296 | 2007 |
| TTI-621 (SIRPαFc): a CD47-blocking innate immune checkpoint inhibitor with broad antitumor activity and minimal erythrocyte binding PS Petrova, NN Viller, M Wong, X Pang, GHY Lin, K Dodge, V Chai, ... Clinical cancer research 23 (4), 1068-1079, 2017 | 263 | 2017 |
| Toxicology of antisense therapeutics TLH Jason, J Koropatnick, RW Berg Toxicology and applied pharmacology 201 (1), 66-83, 2004 | 235 | 2004 |
| Mutagenic action of ascorbic acid HF Stich, J Karim, J Koropatnick, L Lo Nature 260, 722-724, 1976 | 229 | 1976 |
| lo, L.(1976) Mutagenic action of ascorbic acid HF Stich, J Karim, J Koropatnick Nature 260, 722-724, 0 | 229* | |
| Contemporary issues in toxicology: role of metallothionein in carcinogenesis MG Cherian, SB Howell, N Imura, CD Klaassen, J Koropatnick, JS Lazo, ... Toxicology and applied pharmacology 126 (1), 1-5, 1994 | 196 | 1994 |
| Non-covalently functionalized single-walled carbon nanotube for topical siRNA delivery into melanoma KS Siu, D Chen, X Zheng, X Zhang, N Johnston, Y Liu, K Yuan, ... Biomaterials 35 (10), 3435-3442, 2014 | 170 | 2014 |
| COTI-2, a novel small molecule that is active against multiple human cancer cell lines in vitro and in vivo KY Salim, SM Vareki, WR Danter, J Koropatnick Oncotarget 7 (27), 41363, 2016 | 145 | 2016 |
| Exosomes as a tumor immune escape mechanism: possible therapeutic implications TE Ichim, Z Zhong, S Kaushal, X Zheng, X Ren, X Hao, JA Joyce, ... Journal of translational medicine 6, 1-7, 2008 | 141 | 2008 |
| Reinstalling antitumor immunity by inhibiting tumor-derived immunosuppressive molecule IDO through RNA interference X Zheng, J Koropatnick, M Li, X Zhang, F Ling, X Ren, X Hao, H Sun, ... The Journal of Immunology 177 (8), 5639-5646, 2006 | 141 | 2006 |
| Treatment-naïve HPV+ head and neck cancers display a T-cell-inflamed phenotype distinct from their HPV-counterparts that has implications for immunotherapy SF Gameiro, F Ghasemi, JW Barrett, J Koropatnick, AC Nichols, ... Oncoimmunology 7 (10), e1498439, 2018 | 136 | 2018 |
| Detection of circulating tumor cells in advanced head and neck cancer using the CellSearch system AC Nichols, LE Lowes, CCT Szeto, J Basmaji, S Dhaliwal, C Chapeskie, ... Head & neck 34 (10), 1440-1444, 2012 | 130 | 2012 |
| In vivo inhibition of growth of human tumor lines by flavonoid fractions from cranberry extract PJ Ferguson, EM Kurowska, DJ Freeman, AF Chambers, J Koropatnick Nutrition and cancer 56 (1), 86-94, 2006 | 130 | 2006 |
| Metallothionein protects DNA from copper-induced but not iron-induced cleavage in vitro L Cai, J Koropatnick, MG Cherian Chemico-biological interactions 96 (2), 143-155, 1995 | 119 | 1995 |
| The epidemic of human papillomavirus and oropharyngeal cancer in a Canadian population AC Nichols, DA Palma, SS Dhaliwal, S Tan, J Theuer, W Chow, ... Current oncology 20 (4), 212-219, 2013 | 118 | 2013 |
| Arsenic induces and enhances rat hepatic metallothionein production in vivo A Albores, J Koropatnick, MG Cherian, AJ Zelazowski Chemico-biological interactions 85 (2-3), 127-140, 1992 | 110 | 1992 |
| Silencing IDO in dendritic cells: a novel approach to enhance cancer immunotherapy in a murine breast cancer model X Zheng, J Koropatnick, D Chen, T Velenosi, H Ling, X Zhang, N Jiang, ... International journal of cancer 132 (4), 967-977, 2013 | 109 | 2013 |
Mateusz RytelewskiAstraZenecaVerified email at medimmune.com
